Anaheim, CA, United States — July 23, 2026 — The Association for Diagnostics & Laboratory Medicine (ADLM) Annual Meeting, scheduled for July 26-30, 2026, in Anaheim, CA, is projected to host approximately 20,000 professionals and over 800 exhibitors, featuring more than 200 new products and services. This event, formerly recognized as the AACC Annual Scientific Meeting & Clinical Lab Expo, continues its role as a primary global gathering for laboratory medicine. The rebranding from the American Association for Clinical Chemistry (AACC) occurred in 2023, solidifying ADLM's focus on advancing diagnostics and patient care.
Event Overview and Organizational Rigor
The ADLM Annual Meeting will convene at the Anaheim Convention Center in Anaheim, CA, USA. This gathering is a critical platform for scientists, clinicians, laboratory professionals, researchers, and diagnostic innovators. The Association for Diagnostics & Laboratory Medicine (ADLM) serves as the organizing body, with its Annual Meeting Organizing Committee (AMOC) comprising 14 experts who meticulously plan the scientific program. This structure ensures the event addresses current challenges and advancements in laboratory science, directly impacting diagnostic accuracy and patient management.
Advancements in Diagnostic Technologies and Laboratory Efficiency
The Clinical Lab Expo, a central component of the Annual Meeting, will showcase developments across key sectors. The Clinical Chemistry & Molecular Diagnostics sector will highlight advancements in analyzing bodily fluids, including immunoassay platforms, clinical mass spectrometry, next-generation sequencing (NGS), and PCR-based assays. These technologies are crucial for precise disease identification, genetic testing, and oncology, directly informing patient stratification and therapeutic efficacy. The Laboratory Automation & Management sector will focus on solutions designed to enhance operational efficiency. This includes robotic systems, integrated laboratory information management systems (LIMS), and the application of artificial intelligence (AI) and machine learning for data analysis. Such innovations are pivotal for improving diagnostic turnaround times and reducing human error, thereby enhancing the reliability of clinical decision-making and regulatory compliance.
Program Highlights and Professional Engagement
The 2026 ADLM Annual Meeting will offer a robust program with over 250 educational opportunities, including lectures, plenary sessions, and scientific sessions delivered by more than 300 expert speakers. Key attractions include the Clinical Lab Expo, which historically draws 740 to 750 exhibitors and is set to feature over 800 exhibitors and more than 200 new products and services this year. Other highlights encompass translational medicine lectures, hands-on laboratory training, mass clinical lab demonstrations, and the Disruptive Technology Award Competition. For context, the ADLM 2025 event drew nearly 16,500 attendees. The target audience for the 2026 meeting includes lab professionals, clinical chemists, and researchers, alongside laboratory directors and pathologists, all seeking insights into product innovations and best practices.
For further information or registration details, please visit the official website: https://meeting.myadlm.org.